Kathy Sherwood Joins Pelvital USA, Inc. Board of Directors

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Kathy Sherwood, Senior Vice President, Global Market Access of Inspire Medical Systems, has joined Pelvital USA Board of Directors.

Kathy Sherwood is a seasoned medical device professional with 30+ years of industry experience including urology & pelvic health, cardiac rhythm management, neurology, obstructive sleep apnea, wound care, and diagnostics with experience in R&D, operations, sales, marketing, and market access & reimbursement.

Sherwood’s experience, which includes a diverse group of medical product companies such as Boston Scientific, American Medical Systems, St. Jude Medical, Kinetic Concepts, Transoma Medical and Medtronic, gives her an understanding of the problems faced by both large and small companies.

Kathy Sherwood has both U.S. and international experience having lived in the Netherlands for several years, leading a European market access and reimbursement function. In Kathy’s current position at Inspire Medical, Kathy has successfully led efforts to penetrate the market with a new technology to address an unmet and underserved need in obstructive sleep apnea.

“Women I know are suffering in silence from stress urinary incontinence. It is a large, rapidly growing and largely underserved market that affects the quality of people’s lives. The world needs better solutions, and I am very impressed with the clinical outcomes of the work done by the original inventors in Norway and the Pelvital team. I am confident we can help women around the world to regain control of their lives,” Sherwood said. “I am very pleased to be joining the Pelvital Board and to help bring this new technology to women.”

“With extensive experience in direct-to-consumer and clinical marketing, reimbursement, pricing, and commercialization across multiple medical device companies, Kathy is uniquely qualified to help Pelvital transition from a development company into a commercialization company,” said Dale Wahlstrom, CEO of Pelvital. “We look forward to Kathy providing guidance to the Pelvital team as we bring the FlyteTM incontinence product to market.”

Kathy Sherwood holds a Bachelor of Science degree in Mechanical-Industrial Engineering from the University of Illinois, Urbana-Champaign, and an MBA from the University of Minnesota, Carlson School of Management in Minneapolis. She is active in outdoor sports and an involved supporter of charity organizations including the Children’s Hospital Guild and Habitat for Humanity.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.